Published in Dokl Biochem Biophys on July 15, 2004
CombiHIVvac vaccine which contains polyepitope B and T- cell immunogens of HIV-1. Dokl Biochem Biophys (2007) 0.95
Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. Science (1998) 12.05
Progress in the development of an HIV-1 vaccine. Science (1998) 2.77
Beta-chemokines are released from HIV-1-specific cytolytic T-cell granules complexed to proteoglycans. Nature (1998) 2.30
Practical, biochemical and evolutionary implications of the discovery of HLA class I supermotifs. Immunol Today (1996) 1.79
DNA multi-CTL epitope vaccines for HIV and Plasmodium falciparum: immunogenicity in mice. Vaccine (1998) 1.40
Optimization of epitope processing enhances immunogenicity of multiepitope DNA vaccines. Vaccine (2001) 1.38
DNA immunization with minigenes: low frequency of memory cytotoxic T lymphocytes and inefficient antiviral protection are rectified by ubiquitination. J Virol (1998) 1.34
Recombinant polyepitope vaccines for the delivery of multiple CD8 cytotoxic T cell epitopes. J Immunol (1996) 1.07
Design of four-helix bundle protein as a candidate for HIV vaccine. Protein Eng (1995) 0.97
Is an HIV vaccine possible? Nat Med (1999) 0.93
Immunogenicity of a human immunodeficiency virus (HIV) polytope vaccine containing multiple HLA A2 HIV CD8(+) cytotoxic T-cell epitopes. J Virol (1999) 0.92
[The characteristics of the long-term continuous cultivation of a cell line chronically infected with the human immunodeficiency virus type-1]. Vopr Virusol (1992) 0.84
[Searching for local similarities between HIV-1 and human proteins. Application to vaccines]. Mol Biol (Mosk) (2002) 0.83
[Design of recombinant-stable plasmids of the pFH series]. Bioorg Khim (1991) 0.80
Why the smallpox virus stocks should not be destroyed. Science (1993) 1.56
Human monkeypox and smallpox viruses: genomic comparison. FEBS Lett (2001) 1.32
Analysis of the monkeypox virus genome. Virology (2002) 1.27
Genes of variola and vaccinia viruses necessary to overcome the host protective mechanisms. FEBS Lett (1993) 1.23
Design of four-helix bundle protein as a candidate for HIV vaccine. Protein Eng (1995) 0.97
CombiHIVvac vaccine which contains polyepitope B and T- cell immunogens of HIV-1. Dokl Biochem Biophys (2007) 0.95
Comparison of the genetic maps of variola and vaccinia viruses. FEBS Lett (1993) 0.93
Inactivated Marburg virus elicits a nonprotective immune response in Rhesus monkeys. J Biotechnol (1996) 0.92
Analysis of the nucleotide sequence of 53 kbp from the right terminus of the genome of variola major virus strain India-1967. Virus Res (1994) 0.92
Inactivation of viruses in bubbling processes utilized for personal bioaerosol monitoring. Appl Environ Microbiol (2004) 0.92
Ankyrin-like proteins of variola and vaccinia viruses. FEBS Lett (1993) 0.91
[Substrate specificity of restriction endonuclease Kpn378I]. Bioorg Khim (1990) 0.89
Analysis of the nucleotide sequence of 23.8 kbp from the left terminus of the genome of variola major virus strain India-1967. Virus Res (1996) 0.88
[Establishing the substrate specificity of site-specific deoxyribonuclease RtrI]. Bioorg Khim (1991) 0.87
Comparative studies of gamma-interferon receptor-like proteins of variola major and variola minor viruses. FEBS Lett (1996) 0.87
[Site-specific restriction endonuclease RME211 from Rhizobium meliloti]. Mol Gen Mikrobiol Virusol (1991) 0.86
Rational design based synthetic polyepitope DNA vaccine for eliciting HIV-specific CD8+ T cell responses. Mol Immunol (2010) 0.85
[Primary structure of the DNA copy of the protein VP1 gene of the foot-and-mouth disease virus A22]. Bioorg Khim (1986) 0.85
[Modeling spatial structures of variola and cowpox virus TNF-binding CrmB proteins bound to murine or human TNF]. Mol Biol (Mosk) (2011) 0.84
Design of immunogens as components of a new generation of molecular vaccines. J Biotechnol (1996) 0.83
[Design of virus-like particles, exposing HIV-1 epitopes]. Mol Biol (Mosk) (2000) 0.83
[Genetic identification of the Crimean-Congo hemorrhagic fever virus during epidemic outbreak in Kazakhstan in 2000]. Mol Gen Mikrobiol Virusol (2002) 0.82
Novel conjugate of moxifloxacin and carboxymethylated glucan with enhanced activity against Mycobacterium tuberculosis. Antimicrob Agents Chemother (2006) 0.82
Multiple genetic differences between the monkeypox and variola viruses. Dokl Biochem Biophys (2002) 0.82
Infection of chickens caused by avian influenza virus A/H5N1 delivered by aerosol and other routes. Transbound Emerg Dis (2012) 0.82
Highly pathogenic influenza virus H5N1 found in western Siberia is genetically related to viruses that circulated in Southeast Asia in 2003-2005. Dokl Biol Sci (2006) 0.82
[Characteristics of Crimean-Congo hemorrhagic fever virus circulating in Russia and Central Asia]. Vopr Virusol (2002) 0.82
[The effect of peptides-analogs of T4 receptor and HLA class II antigens on the reproduction of human immunodeficiency virus]. Dokl Akad Nauk SSSR (1990) 0.82
[Construction of original artificial immunogens--candidate vaccines against HIV-1]. Mol Gen Mikrobiol Virusol (2000) 0.81
[Entire coding sequence of the variola virus]. Dokl Akad Nauk (1993) 0.81
[Experimental study of Ebola hemorrhagic fever in baboon models]. Biull Eksp Biol Med (1995) 0.81
The use of interferon for emergency prophylaxis of marburg hemorrhagic fever in monkeys. Bull Exp Biol Med (2001) 0.81
[Comparison of the amino acid sequence of structural proteins from attenuated and pathogenic strains of the Venezuelan equine encephalomyelitis virus]. Dokl Akad Nauk SSSR (1991) 0.81
[A comparative study of the immunological indices in guinea pigs administered an inactivated Marburg virus]. Vopr Virusol (1992) 0.80
[Immunogenic and protective characteristics of recombinant Lassa virus NP protein]. Vopr Virusol (2002) 0.80
New restriction endonucleases from thermophilic soil bacteria. Gene (1995) 0.80
[Production of a viable variant of the M13 phage with a foreign peptide inserted into the basic coat protein]. Dokl Akad Nauk SSSR (1989) 0.80
Immunization with recombinant vaccinia viruses expressing structural and part of the nonstructural region of tick-borne encephalitis virus cDNA protect mice against lethal encephalitis. J Biotechnol (1996) 0.79
[Experimental study of possible treatment of Marburg hemorrhagic fever with desferal, ribavirin, and homologous interferon]. Vopr Virusol (1996) 0.79
[Apoptin enhances the oncolytic activity of vaccinia virus]. Mol Biol (Mosk) (2014) 0.79
[The immunogenic properties of Marburg virus proteins]. Vopr Virusol (1992) 0.79
[Effects of tumor necrosis factor antiserum of the course of Marburg hemorrhagic fever]. Vestn Ross Akad Med Nauk (1998) 0.79
[Study of the structure-activity organization of the smallpox viral genome. V. Sequencing and analysis of the nucleotide sequence of the left terminus of the India-1967 strain genome]. Mol Biol (Mosk) (1996) 0.79
[Molecular characteristic of influenza virus A H5N1 Strains isolated from poultry in Kurgan Region in 2005]. Mol Biol (Mosk) (2008) 0.78
[Localization of the HIV-1 gp120 conformational epitope recognized by virus neutralizing monoclonal antibodies 2G12]. Mol Biol (Mosk) (2002) 0.78
[Chimeric hepatitis B core antigen particles as a presentation system of foreign protein epitopes]. Vestn Ross Akad Med Nauk (1998) 0.78
[A preparative procedure for the isolation of enriched preparations of aminoacyl-tRNA-synthetases from baker's yeast]. Biokhimiia (1968) 0.78
Genetic analysis of the M RNA segment of Crimean-Congo hemorrhagic fever virus strains involved in the recent outbreaks in Russia. Arch Virol (2004) 0.78
[In vivo efficacy of Ingavirin against pandemic A (H1N1/09)v influenza virus]. Antibiot Khimioter (2010) 0.78
[Study of certain indicators of immunity upon infecting CBA/Calac line mice with Lassa virus]. Vopr Virusol (1995) 0.78
Development of a candidate polyvalent live vaccine against human immunodeficiency, hepatitis B, and orthopox viruses. Dokl Biochem Biophys (2003) 0.78
A test for the "degeneracy" of valine-acceptor ribonucleic acid. Biochim Biophys Acta (1965) 0.78
[Mechanisms of HIV-1 drug resistance to nucleoside and non-nucleoside reverse transcriptase inhibitors]. Mol Biol (Mosk) (2011) 0.78
Comparative assessment of the properties of orthopoxviral soluble receptors for tumor necrosis factor. Dokl Biochem Biophys (2003) 0.78
[Preparation of enriched valine-acceptor soluble RNA from baker's yeasts]. Dokl Akad Nauk SSSR (1965) 0.78
[Effect of promoter duplication in the synthetic interferon gene on the level of its expression]. Genetika (1987) 0.77
Symptoms of infection caused by SARS coronavirus in laboratory mice and guinea pigs. Dokl Biol Sci (2004) 0.77
Phylogenetic comparison of the genomes of different strains of variola virus. Dokl Biochem Biophys (2004) 0.77
[ELISA and RT-PCR-based research of viruses in the ticks collected in the foci of Crimean-Congo fever in Kazakhstan and Tajikistan in 2001-2002]. Vopr Virusol (2005) 0.77
[The immunity indices of animals immunized with the inactivated Marburg virus after infection with homologous virus]. Vopr Virusol (1994) 0.77
Species-specific differences in the organization of genes encoding kelch-like proteins of orthopoxviruses pathogenic for humans. Dokl Biochem Biophys (2002) 0.77
[Genetic characteristics of the S-segment of RNA from two strains of the Crimean-Congo hemorrhagic fever virus isolated in the south of Russia and in Uzbekistan]. Vopr Virusol (2003) 0.77
Inserting foreign peptides into the major coat protein of bacteriophage M13. FEBS Lett (1992) 0.77
[Mechanisms of protective immune response in models of Marburg fever in monkeys]. Vopr Virusol (1995) 0.77
[Effect of mutations in genes of Venezuelan equine encephalomyelitis virus structural proteins on its attenuation]. Dokl Akad Nauk (1992) 0.77
[Genetic variability of isolates of pandemic influenza A virus H1N1 isolated in Russia in 2009]. Mol Gen Mikrobiol Virusol (2011) 0.77
Species-specific differences in the organization of the complement-binding protein of orthopoxviruses. Dokl Biochem Biophys (2001) 0.77
[Expression of genes for orthopoxviral TNF-binding proteins and study resulted recombinant proteins]. Mol Biol (Mosk) (2005) 0.76
[Nucleotide sequence of genes and complete amino acid sequence of tick-borne encephalitis virus strain 205]. Mol Gen Mikrobiol Virusol (1991) 0.76
[An experimental study of possibility of treatment of hemorrhagic fever Marburg by Remicade]. Vestn Ross Akad Med Nauk (2004) 0.76
[Comparative study of hemostasis and cytokine production in experimental Dengue virus infection]. Vopr Virusol (2007) 0.76
[Study of virus contamination of Ixodes ticks in the foci of Crimean-Congo hemorrhagic fever in Kazakhstan and Tajikistan]. Zh Mikrobiol Epidemiol Immunobiol (2005) 0.76
Mutant human gamma-interferon with a truncated C-terminus and its properties. Dokl Biochem (2000) 0.76
[Highly pathogenic avian influenza: a new pandemic threat and possibilities to resist it]. Vestn Ross Akad Med Nauk (2006) 0.76
[Human mini-antibodies to orthopoxviruses]. Vestn Ross Akad Med Nauk (2004) 0.76
The full-length recombinant human antibody to vaccinia virus. Dokl Biochem Biophys (2006) 0.76
[Immunogenetic properties of peptides mimicking a human immunodeficiency virus gp41 (HIV-1) epitope recognized by virus-neutralizing antibody 2F5]. Mol Biol (Mosk) (2003) 0.76